Evidence map›Paper›PMID 37971537›Full record

ArticleEuropean journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology2024

Epidemiology and molecular typing of multidrug-resistant bacteria in tertiary hospitals and nursing homes in Flanders, Belgium.

Stefanie van Kleef-van Koeveringe, Veerle Matheeussen, Annette Schuermans, Sien De Koster, Natascha Perales Selva, Hilde Jansens, Dieter De Coninck, Katrien De Bruyne, Klaas Mensaert, Marjolein Kluytmans-van den Bergh and 5 more

Open access · hybridAbstract read
In one paragraph

Article in European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.1field-weighted citation impact, top 64% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 6 institutions in 4 countries.

Stefanie van Kleef-van KoeveringeLaboratory of Medical Microbiology, University Hospital Antwerp, Edegem, Belgium. Stefanie.vanKoeveringe@uza.be.ORCID http://orcid.org/0000-0001-9500-3674
Veerle MatheeussenLaboratory of Medical Microbiology, University Hospital Antwerp, Edegem, Belgium.ORCID https://orcid.org/0000-0003-2137-2068
Annette SchuermansDepartment of Infection Control and Epidemiology, University Hospital Leuven, Leuven, Belgium.
Sien De KosterDepartment of Medical Microbiology, Vaccine & Infectious Disease Institute (VAXINFECTIO), University of Antwerp, Wilrijk, Belgium.ORCID https://orcid.org/0000-0002-5267-5080
Natascha Perales SelvaLaboratory of Medical Microbiology, University Hospital Antwerp, Edegem, Belgium.
Hilde JansensDepartment of Infection Control, University Hospital Antwerp, Edegem, Belgium.
Dieter De ConinckbioMérieux, Augmented Diagnostics, Industrial Microbiology, Applied Maths NV, Sint-Martens-Latem, Belgium.
Katrien De BruynebioMérieux, Augmented Diagnostics, Industrial Microbiology, Applied Maths NV, Sint-Martens-Latem, Belgium.ORCID https://orcid.org/0000-0001-7105-3001
Klaas MensaertbioMérieux, Augmented Diagnostics, Industrial Microbiology, Applied Maths NV, Sint-Martens-Latem, Belgium.
Marjolein Kluytmans-van den BerghDepartment of Infection Control, Amphia Hospital, Breda, The Netherlands.ORCID https://orcid.org/0000-0002-6576-6408
Jan KluytmansMicrovida Laboratory for Microbiology, Amphia Hospital, Breda, and Department of Medical Microbiology, University Medical Center Utrecht, Utrecht, The Netherlands.
Herman GoossensLaboratory of Medical Microbiology, University Hospital Antwerp, Edegem, Belgium.
Wouter DhaezeDepartment prevention, Agentschap Zorg en Gezondheid, Leuven, Belgium.
Isabel Leroux-RoelsLaboratory of Medical Microbiology, University Hospital Ghent, Ghent, Belgium.ORCID https://orcid.org/0000-0002-5084-4696
i-4-1-Health Study Group
University of Antwerp · BEbioMérieux (United States) · USAntwerp University Hospital · BEUniversity Medical Center Utrecht · NLGhent University Hospital · BEKU Leuven · BE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study aimed to map MDRO carriage and potential transmission within and between three Flemish tertiary care hospitals and their neighbouring nursing homes. A cross-sectional MDRO prevalence survey was organized between October 2017 and February 2019. Perianal swabs were cultured for detection of MDRO. Determination of clonal relatedness based on wgMLST allelic profiles was performed. The prevalence of MDRO in Belgian hospitals and NHs is on the rise, compared to previous studies, and transmission in and between institutions is observed. These results re-emphasize the need for a healthcare network-wide infection prevention strategy in which WGS of MDRO strains can be supportive.

Indexed as

Cross InfectionNursing HomesBacteriaBelgiumCross-Sectional StudiesDrug Resistance, Multiple, BacterialHumansMolecular TypingTertiary Care CentersMDROMolecular typingScreeningTransmissionwgMLSTWhole-genome sequencing

Identifiers

PMID37971537
PMCPMC10774642
OpenAlexW4388733847

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.